Diabetes treatment--bridging the divide.
作者信息
Rother Kristina I
机构信息
Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
出版信息
N Engl J Med. 2007 Apr 12;356(15):1499-501. doi: 10.1056/NEJMp078030.
Abstract
摘要
相似文献
1
Diabetes treatment--bridging the divide.糖尿病治疗——弥合差距。
N Engl J Med. 2007 Apr 12;356(15):1499-501. doi: 10.1056/NEJMp078030.
2
The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.白细胞介素-1受体拮抗剂在糖尿病治疗中的应用。
Nat Clin Pract Endocrinol Metab. 2008 May;4(5):240-1. doi: 10.1038/ncpendmet0783. Epub 2008 Mar 4.
3
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.2型糖尿病中的白细胞介素-1受体拮抗剂
N Engl J Med. 2007 Apr 12;356(15):1517-26. doi: 10.1056/NEJMoa065213.
4
The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance.白细胞介素-1受体拮抗剂阿那白滞素可改善糖耐量受损受试者的第一相胰岛素分泌和胰岛素生成指数。
Diabetes Obes Metab. 2014 Dec;16(12):1269-73. doi: 10.1111/dom.12357. Epub 2014 Aug 13.
5
[Survey of recent clinical trials of the prevention and immunointervention of type 1 diabetes mellitus].[1型糖尿病预防与免疫干预近期临床试验综述]
Dtsch Med Wochenschr. 2010 Feb;135(8):350-4. doi: 10.1055/s-0030-1249169. Epub 2010 Feb 17.
6
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.抗白细胞介素-1 治疗类风湿关节炎合并 2 型糖尿病患者（TRACK）：一项多中心、开放标签、随机对照试验。
PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep.
7
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
N Engl J Med. 2007 Jul 19;357(3):302-3; author reply 303. doi: 10.1056/NEJMc071324.
8
Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.对阿维A和肿瘤坏死因子抑制剂耐药的Hallopeau连续性肢端皮炎对白细胞介素1受体拮抗剂阿那白滞素有效。
Arch Dermatol. 2012 Mar;148(3):297-9. doi: 10.1001/archdermatol.2011.2473.
9
Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats.白细胞介素-1 受体拮抗剂改善糖尿病 Goto-Kakizaki 大鼠的血糖正常和胰岛素敏感性。
Eur J Pharmacol. 2013 Feb 15;701(1-3):87-95. doi: 10.1016/j.ejphar.2013.01.008. Epub 2013 Jan 21.
10
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.白细胞介素-1受体拮抗剂治疗2型糖尿病的持续效果。
Diabetes Care. 2009 Sep;32(9):1663-8. doi: 10.2337/dc09-0533. Epub 2009 Jun 19.
引用本文的文献
1
Vanadyl Acetylacetonate and Berberine Synergistically Ameliorate Diabetes-induced Vascular Dysfunction and Reduce Endothelial Toxicity through ERK and Akt Regulation.乙酰丙酮氧钒和小檗碱通过调控ERK和Akt协同改善糖尿病诱导的血管功能障碍并降低内皮毒性。
Biol Trace Elem Res. 2025 Aug 7. doi: 10.1007/s12011-025-04774-z.
2
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).肥胖与慢性炎症在代谢功能紊乱表现中的分子和病理生理学关系及其炎症介导的治疗选择（综述）。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12.
3
Modulation of Neuronal Damage in DRG by Asprosin in a High-Glucose Environment and Its Impact on miRNA181-a Expression in Diabetic DRG.高糖环境中天门冬素对 DRG 神经元损伤的调节及其对糖尿病性 DRG 中 miRNA181-a 表达的影响。
Neurotox Res. 2023 Dec 22;42(1):5. doi: 10.1007/s12640-023-00678-9.
4
Evaluation of the expression of genes associated with iron metabolism in peripheral blood mononuclear cells from Type 2 diabetes mellitus patients.评估 2 型糖尿病患者外周血单个核细胞中与铁代谢相关基因的表达。
Free Radic Biol Med. 2024 Jan;210:344-351. doi: 10.1016/j.freeradbiomed.2023.11.042. Epub 2023 Dec 4.
5
Synergic effects of , and extracts mixture on learning and memory deficits in streptozocin-induced diabetic rats.[具体提取物名称]提取物混合物对链脲佐菌素诱导的糖尿病大鼠学习和记忆缺陷的协同作用。 （原文中“ , and ”部分内容缺失，请补充完整具体提取物名称，以便准确翻译）
Iran J Basic Med Sci. 2023;26(12):1490-1497. doi: 10.22038/IJBMS.2023.70096.15246.
6
Theoretical Studies for the Discovery of Potential Sucrase-Isomaltase Inhibitors from Maize Silk Phytochemicals: An Approach to Treatment of Type 2 Diabetes.从玉米丝植物化学物质中发现潜在蔗糖酶-异麦芽糖酶抑制剂的理论研究：治疗 2 型糖尿病的一种方法。
Molecules. 2023 Sep 23;28(19):6778. doi: 10.3390/molecules28196778.
7
Exploring Serum Transferrin Regulation of Nonferric Metal Therapeutic Function and Toxicity.探索血清转铁蛋白对非铁金属治疗功能和毒性的调节作用。
Inorganics (Basel). 2020 Sep;8(9). doi: 10.3390/inorganics8090048. Epub 2020 Aug 29.
8
Vanin 1 Gene Role in Modulation of iNOS/MCP-1/TGF-β1 Signaling Pathway in Obese Diabetic Patients.血管生成素1基因在肥胖糖尿病患者iNOS/MCP-1/TGF-β1信号通路调节中的作用
J Inflamm Res. 2022 Dec 14;15:6745-6759. doi: 10.2147/JIR.S386506. eCollection 2022.
9
Known data on the therapeutic use of (neem) for type 2 diabetes mellitus.关于印楝用于2型糖尿病治疗用途的已知数据。
Bioinformation. 2022 Feb 28;18(2):82-87. doi: 10.6026/97320630018082. eCollection 2022.
10
A comprehensive overview on Micro RNA signature in type 2 diabetes Mellitus and its complications.2型糖尿病及其并发症中微小RNA特征的综合概述。
Indian J Clin Biochem. 2023 Apr;38(2):151-158. doi: 10.1007/s12291-022-01069-1. Epub 2022 Sep 5.
本文引用的文献
1
Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.一名接受白细胞介素1受体抑制剂阿那白滞素治疗的成人斯蒂尔病患者发生心脏性死亡。
Ann Rheum Dis. 2007 Mar;66(3):422-3. doi: 10.1136/ard.2006.060541. Epub 2006 Dec 19.
2
Inflammation and metabolic disorders.炎症与代谢紊乱。
Nature. 2006 Dec 14;444(7121):860-7. doi: 10.1038/nature05485.
3
IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?白细胞介素-1受体拮抗剂在代谢性疾病中的作用：善还是恶？
FEBS Lett. 2006 Nov 27;580(27):6289-94. doi: 10.1016/j.febslet.2006.10.061. Epub 2006 Nov 3.
4
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?长期1型糖尿病患者中持续的β细胞凋亡：胰岛再生的间接证据？
Diabetologia. 2005 Nov;48(11):2221-8. doi: 10.1007/s00125-005-1949-2. Epub 2005 Oct 5.
Zotero 插件